News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Genentech, Inc. (JOBS) CEO Sells 90,000 Shares Prior to Roche (JOBS) Bid
July 23, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK (Reuters) - If there was any doubt that Genentech Inc was caught by surprise by Roche's move to acquire the remaining stake in the biotechnology giant it doesn't already own, one need only look at recent executive stock transactions.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Genentech, Inc.
Roche
MORE ON THIS TOPIC
Series A
New biotech cAMPfield emerges with $180M to reshape IBD treatment
June 18, 2026
·
2 min read
·
Gabrielle Masson
Manufacturing
Moderna mulls deals to rescue German BioNTech plants from closure: report
June 18, 2026
·
2 min read
·
Nick Paul Taylor
Mergers & acquisitions
Biogen makes up to $1B immuno play with RayThera takeover
June 18, 2026
·
2 min read
·
Tristan Manalac
Deals
Jazz strikes new chord with AbCellera in T cell engager pact that could top $2.4B
June 17, 2026
·
2 min read
·
Gabrielle Masson